Luu Brendan — SEC Form 4 filings
SEC reporting owner CIK 1842369. 9 Form 4 filings on record with FilingPulse; latest filed 2026-02-13.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-14 to 2026-02-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 3,677 shares, $38,238 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 1,394 shares @ $14.23 ($19,837) in ENANTA PHARMACEUTICALS INC, filed 2025-12-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | Chief Business Officer | 9 | — | 2 legs · 3,677 sh · $38,238 | 11 |
Form 4 filings — Luu Brendan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-13 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 1,575 @ $0 · Grant/award (A): 4,987 @ $0 · Tax withholding (F): 3,257 @ $14.25 | EDGAR |
| 2025-12-05 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Sale (S): 1,394 @ $14.23 | EDGAR |
| 2025-12-03 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Tax withholding (F): 498 @ $14.12 | EDGAR |
| 2025-11-26 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 7,500 @ $0 · Tax withholding (F): 3,326 @ $5.59 | EDGAR |
| 2024-12-10 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Sale (S): 2,283 @ $8.06 | EDGAR |
| 2024-12-03 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Tax withholding (F): 753 @ $8.60 | EDGAR |
| 2024-11-27 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/award (A): 3,320 @ $0 · Tax withholding (F): 973 @ $12.41 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1842369 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →